Factor Xa is an important target for the development of new anticoagulants.The present study aims to examine the effect of three compounds (Quercetin and its derivatives Rutin and Troxerutin) in comparison with Rivaroxaban on activated Human Clotting factor X (PDB ID: 2w26).Molecular docking was performed using iGemDock v2.1 software to predict their antiactivating factor X activity and Autodock v...